Description
RegadenosonisanadenosineA2AreceptoragoNISTthatdisplaysvasodilatoryactivity.Regadenosonisclinicallyusedinmyocardialperfusionimaging.
RegadenosonisanadenosineA2AreceptoragoNISTthatdisplaysvasodilatoryactivity.Regadenosonisclinicallyusedinmyocardialperfusionimaging.
CasNo. | 313348-27-5 |
---|---|
Purity | ≥99% |
Formula | C15H18N8O5 |
FormulaWt. | 390.35 |
IUPACName | 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide |
Appearance | Whitetooffwhitepowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
InfoSheet | R1724InfoSheetPDF |
---|
PalaniG,AnanthasubramaniamK.Regadenoson:reviewofitsestablishedroleinmyocardialperfusionimagingandemergingapplications.CardiolRev.2013Jan-Feb;21(1):42-8.PMID:22643345.
CerqueiraMD.Thefutureofpharmacologicstress:selectiveA2Aadenosinereceptoragonists.AmJCardiol.2004Jul22;94(2A):33D-40D;discussion40D-42D.PMID:15261132.